RT Journal Article
SR Electronic
T1 Presentation of long COVID and associated risk factors in a mobile health study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.09.27.22280404
DO 10.1101/2022.09.27.22280404
A1 Stewart, Callum
A1 Ranjan, Yatharth
A1 Conde, Pauline
A1 Sun, Shaoxiong
A1 Rashid, Zulqarnain
A1 Sankesara, Heet
A1 Cummins, Nicholas
A1 Laiou, Petroula
A1 Bai, Xi
A1 Dobson, Richard J B
A1 Folarin, Amos A
YR 2022
UL http://medrxiv.org/content/early/2022/09/27/2022.09.27.22280404.abstract
AB Backgroun The Covid Collab study was a citizen science mobile health research project set up in June 2020 to monitor COVID-19 symptoms and mental health through questionnaire self-reports and passive wearable device data.Methods Using mobile health data, we consider whether a participant is suffering from long COVID in two ways. Firstly, by whether the participant has a persistent change in a physiological signal commencing at a diagnosis of COVID-19 that last for at least twelve weeks. Secondly, by whether a participant has self-reported persistent symptoms for at least twelve weeks. We assess sociodemographic and wearable-based risk factors for the development of long COVID according to the above two categorisations.Findings Persistent changes to physiological signals measured by commercial fitness wearables, including heart rate, sleep, and activity, are visible following a COVID-19 infection and may help differentiate people who develop long COVID. Anxiety and depression are significantly and persistently affected at a group level following a COVID-19 infection. We found the level of activity undertaken in the year prior to illness was protective against long COVID and that symptoms of depression before and during the acute illness may be a risk factor.Interpretation Mobile health and wearable devices may prove to be a useful resource for tracking recovery and presence of long-term sequelae to COVID-19. Mental wellbeing is significantly negatively effected on average for an extended period of time following a COVID-19 infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the NIHR Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and Kings College London but did not receive specific funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:PNM Research Ethics Panel of King's College London gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData from participants who consented to share an anonymised copy are available on reasonable request to the authors.